NCT05453487: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
- State
- State not given
- Phase
- Phase 4
- People
- 360 planned
- Started
- 21 Jul 2022
- Primary completion
- 30 Oct 2022
- Arms
- Rabies vaccine group
- Results
- None posted
- 12 Jul 2022: Trial registered
- 21 Jul 2022: Trial started